AIVITA Biomedical to Exhibit New ROOT OF SKIN™ MD Skincare Products at A4M World Congress

IRVINE, Calif. – December 12, 2018 – AIVITA Biomedical, Inc. today announced that it will be exhibiting at The American Academy of Anti-Aging Medicine (A4M) World Congress, taking place December 13-15 at the Venetian Palazzo Resort in Las Vegas, Nevada. There attendees will be able to meet with the developers and sales team behind ROOT OF SKIN™ MD, AIVITA’s professional line of rejuvenating skincare products.

ROOT OF SKIN™ MD is AIVITA’s professional skincare line for skin rejuvenation, made possible through the same proprietary knowledge and expertise used to develop its cutting-edge stem cell therapies. The all-new actives complex SourceCode Technology™ contains the complete set of factors and supporting biological components present in young, healthy skin.

“ROOT OF SKIN is well suited to this meeting, which focuses on emerging innovations and future scientific advances in anti-aging medicine,” said Dr. Aleksandra Poole, AIVITA’s Vice President of Research who will attend the conference. “We will present new third-party clinical data that irrefutably establishes our active ingredient as a breakthrough in anti-aging medicine.”

All proceeds from the sale of ROOT OF SKIN™ MD products support the treatment of women with ovarian cancer.


ROOT OF SKIN™ is a rejuvenating line of skincare products fueled by an unrelenting pursuit for advancements in life-changing and life-saving treatments. Harnessing breakthroughs in stem cell therapy, AIVITA Biomedical developed a technology that does more than just boost regeneration. The patented actives complex SourceCode Technology™ renews, repairs and protects, just as your skin did at its youngest and healthiest stage. Rich with every biological component healthy skin needs for development, and free of any unnecessary ingredients. All proceeds support treatment of women with ovarian cancer.

About AIVITA Biomedical

AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its therapeutic pipeline and commercial line of skin care products.